Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer (Q37155592)
Jump to navigation
Jump to search
scientific article published on 15 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer |
scientific article published on 15 December 2008 |
Statements
1 reference
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer (English)
1 reference
Pamela J Atherton
1 reference
Edith A Perez
1 reference
Stephanie L Hines
1 reference
Betty Anne Mincey
1 reference
Jeff A Sloan
1 reference
Sachdev P Thomas
1 reference
Elaine Chottiner
1 reference
Charles L Loprinzi
1 reference
Mark D Carlson
1 reference
Muhammad Salim
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference